Compare PRAX & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | NRDS |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 631.6M |
| IPO Year | 2020 | 2021 |
| Metric | PRAX | NRDS |
|---|---|---|
| Price | $299.33 | $9.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $572.13 | $15.00 |
| AVG Volume (30 Days) | 296.5K | ★ 574.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.42 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $836,600,000.00 |
| Revenue This Year | N/A | $10.13 |
| Revenue Next Year | $7,758.26 | $7.11 |
| P/E Ratio | ★ N/A | $24.92 |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $41.78 | $7.33 |
| 52 Week High | $392.70 | $16.24 |
| Indicator | PRAX | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 30.44 | 38.64 |
| Support Level | $290.53 | $9.07 |
| Resistance Level | $328.24 | $9.75 |
| Average True Range (ATR) | 14.50 | 0.25 |
| MACD | -6.89 | -0.08 |
| Stochastic Oscillator | 5.68 | 8.78 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.